Research feed

Latest Diabetes Research

Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.

Sorted by publication date. Some studies may have been added to Dediabetes later.

Last updated: Aug 25, 2026890 studies indexed

July 2026

Published Jul 5, 2026RCTs

Adding sitagliptin to insulin improves glycemic control in type 2 diabetes

This study evaluated the efficacy and safety of adding sitagliptin to insulin treatment in patients with type 2 diabetes, finding significant reductions in HbA1c and hypoglycemia incidence.

Interventions
Insulin plus SitagliptinInsulin therapy
Outcomes
HbA1cHypoglycemia eventsTreatment satisfaction
Added to Dediabetes Jul 5, 2026
Published Jul 5, 2026RCTs

Liraglutide is well tolerated in diabetes patients undergoing hemodialysis.

This study investigated the effects of hemodialysis on plasma glucose and liraglutide levels in patients with diabetes and end-stage renal disease, finding significant increases in maximum glucose and glycemic variability.

Interventions
Liraglutide
Outcomes
AUC during hypoglycemia (<70 mg/dL)Blood glucoseDuration of hypoglycemia+8 more
Added to Dediabetes Jul 5, 2026
Published Jul 5, 2026RCTs

Empagliflozin reduces body fluid volume in type 2 diabetes patients

This study compared the effects of empagliflozin and glimepiride on endothelial function in individuals with type 2 diabetes, finding no significant differences in flow-mediated dilation but notable differences in body weight and fluid volume.

Interventions
EmpagliflozinGlimepiride
Outcomes
Body weightBrachial artery flow-mediated dilation (FMD)HbA1c+1 more
Added to Dediabetes Jul 5, 2026
Published Jul 5, 2026Non Randomized CT

High-Dose Vitamin D May Prolong Remission in Type 1 Diabetes

This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.

Interventions
Vitamin D supplementation
Outcomes
HbA1cInsulin-dose adjusted A1c (IDAA1c)Serum 25-hydroxyvitamin D+2 more
Added to Dediabetes Jul 2, 2026
Published Jul 5, 2026RCTs

Luseogliflozin improves glycemic control in older adults with T2D

This study investigated the effects of Luseogliflozin combined with leucine-enriched amino acid supplementation and exercise in older adults with type 2 diabetes. It found a decrease in HbA1c and body weight over 52 weeks.

Interventions
Luseogliflozin
Outcomes
Body fat massBody weightFive-times Sit-to-Stand Test+3 more
Added to Dediabetes Jul 2, 2026
Published Jul 5, 2026RCTs

Cholecalciferol may reduce depression in type 2 diabetes patients

This study investigated the effects of cholecalciferol on depression in patients with type 2 diabetes, finding significant improvements in depression scores compared to placebo.

Interventions
Cholecalciferol
Outcomes
C-peptideDepression scoreNeurotrophin-3+1 more
Added to Dediabetes Jul 2, 2026
Published Jul 5, 2026RCTs

Machine Learning Improves Glycemic Event Prediction in Diabetes

This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.

Interventions
Insulin adjustment module
Outcomes
Blood glucosePostprandial hyperglycemia incidencePostprandial hypoglycemia incidence+1 more
Added to Dediabetes Jun 13, 2026
Published Jul 5, 2026RCTs

Postpartum lifestyle intervention may reduce type 2 diabetes risk

This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.

Interventions
Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)
Outcomes
Cost-effectiveness assessmentDietary intake changesGestational diabetes mellitus incidence+2 more
Added to Dediabetes Jun 12, 2026

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.